P Sherrill Neff
CIK 1189158 · last filed 2026-08-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CEMP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1845 WALNUT STREET, 18TH FLOOR
PHILADELPHIA, PA 19103
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACR | Director | 35,286 | $11.86 | $418.5K | $0 | 15 | 2026-08-07 |
| MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Director | 2,529,642 | — | — | $8.99M | 8 | 2016-10-07 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Director | — | — | — | $0 | 1 | 2015-01-06 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | Director | 143,780 | — | — | $287.2K | 2 | 2014-01-03 |
| ACRES Commercial Realty Corp. (RSO) Delisted | Director | 6,939 | — | — | -$181.1K | 7 | 2012-03-14 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 1,419,762 | $14.49 | $20.57M | $0 | 4 | 2010-06-17 |
Recent Filings · Page 4 of 4
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-03-10 | ACRES Commercial Realty Corp. (RSO) Delisted | Grant (A) | +3,214 | $0 | EDGAR |
| 2009-06-11 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-03-11 | ACRES Commercial Realty Corp. (RSO) Delisted | Grant (A) | +11,479 | $0 | EDGAR |
| 2008-06-13 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-03-11 | ACRES Commercial Realty Corp. (RSO) Delisted | Exer (M) | +3,750 | $0 | EDGAR |
| 2007-06-07 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Conv (C) | +1,419,762 | $0 | EDGAR |
| 2007-03-12 | ACRES Commercial Realty Corp. (RSO) Delisted | Exer (M) | +897 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.